Sodium Benzoate vs Neotame: which is worse?

What is Sodium Benzoate?

Sodium benzoate is the sodium salt of benzoic acid (C7H5NaO2). In acidic foods and beverages, it converts to benzoic acid, which inhibits microbial growth. While benzoic acid occurs naturally in some fruits and spices at low levels, the commercial preservative is synthetically manufactured.

What is Neotame?

Neotame is a synthetic dipeptide sweetener — a derivative of aspartame with a 3,3-dimethylbutyl group added to block aspartame's metabolism, preventing the release of phenylalanine. This means it is safe for people with phenylketonuria (PKU), unlike aspartame. It is approximately 7,000-13,000 times sweeter than sucrose.

Documented risks

Sodium Benzoate: Sodium benzoate's most significant documented concern is the benzene formation reaction. When sodium benzoate coexists with ascorbic acid (vitamin C) in acidic conditions, they react in the presence of metal ions (iron, copper) and UV light to produce benzene, an IARC Group 1 human carcinogen. FDA surveys in 2005-2007 found benzene exceeding the EPA drinking water standard (5 ppb) in 79 of 200 commercial beverages tested. This triggered voluntary reformulations across the beverage industry. The 2007 McCann et al. Lancet study showed that the combination of sodium benzoate with six artificial food dyes significantly increased hyperactivity in children — the effect was synergistic, with the combination producing greater behavioral effects than either ingredient alone. This finding led directly to the EU's mandatory warning label requirement for products combining sodium benzoate with specified dyes. A 2010 study in ADHD: Attention Deficit and Hyperactivity Disorders found associations between urinary sodium benzoate/hippuric acid metabolite levels and ADHD symptom severity in children, independent of dye exposure. A 2019 study in Nutrients (PMC6520673) found similar associations in Korean children. Mitochondrial DNA damage: Dr. Peter Piper at the University of Sheffield found that sodium benzoate at concentrations used in some beverages could damage mitochondrial DNA in yeast cells, potentially affecting mitochondrial function. These findings have not been fully replicated in human tissue studies. Hypersensitivity reactions including urticaria, angioedema, and contact dermatitis are documented. Cross-reactivity with aspirin has been reported in aspirin-sensitive individuals.

Neotame: Neotame is one of the newer synthetic sweeteners with a shorter safety track record. A 2023 study published in Frontiers in Nutrition found that neotame damaged intestinal epithelial cells in vitro and disrupted the gut microbiome in mice — including reducing beneficial bacteria and increasing bacterial invasion of intestinal cells. The study observed effects at concentrations that could be achievable through high consumption of neotame-containing products. The FDA has set an ADI of 0.3 mg/kg/day, one of the lower sweetener ADIs, reflecting a conservative safety margin. Limited long-term human safety data exist compared to aspartame, acesulfame K, or saccharin, which have been used for decades. EFSA's 2010 opinion found no safety concern at permitted levels. The Frontiers in Nutrition 2023 gut study represents new concerning findings that warrant further investigation.